Bajaj Healthcare Limited (BHL), one of the leading manufacturers of API and formulations, has announced that it has received FDA approval for manufacturing Hydroxychloroquine Sulphate Bulk Drug and formulation for its tablets. Hydroxychloroquine Sulphate has been recommended by several countries, including the US, with limited dosage for Covid-19 patients and as a- preventive for high-risk…
Innoplexus AG announced some first results in its artificial intelligence enabled search for a COVID-19 antiviral treatment. Innoplexus began by scanning data on previously approved drugs for off-label potential in treating COVID-19, using its proprietary artificial intelligence (AI) and big data platform to generate actionable insights from hundreds of terabytes of structured and unstructured public…